Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
New antiretroviral drugs and approaches to HIV treatment.
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.
Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads.
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.